NIMOTOP

This brand name is authorized in Austria, Canada, Cyprus, Germany, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, South Africa

Active ingredients

The drug NIMOTOP contains one active pharmaceutical ingredient (API):

1 Nimodipine UNII 57WA9QZ5WH - NIMODIPINE

Nimodipine is a dihydropyridine calcium channel blocker with particular cerebrovascular effect. Nimodipine increases cerebral perfusion, particularly in poorly perfused areas, by arterial dilatation, an effect which is proportionately greater in smaller than in larger vessels. Read about Nimodipine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
NIMOTOP 0.02% Solution for infusion	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC
NIMOTOP Film-coated tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C08CA06	Nimodipine	C Cardiovascular system → C08 Calcium channel blockers → C08C Selective calcium channel blockers with mainly vascular effects → C08CA Dihydropyridine derivatives
Discover more medicines within C08CA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02325926
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00165333, 01549969, 03673254, 06151384
Country: EE	Ravimiamet	Identifier(s): 1006254, 1006287, 1510221
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 58075
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 086553, 086587
Country: FR	Base de données publique des médicaments	Identifier(s): 61339638, 65726536
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 373063, 38794
Country: HK	Department of Health Drug Office	Identifier(s): 28973, 28974
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-331612666, HR-H-637102533
Country: IE	Health Products Regulatory Authority	Identifier(s): 36517
Country: MT	Medicines Authority	Identifier(s): AA639/02402, MA639/02401
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 122M88, 123M88
Country: NL	Z-Index G-Standaard	Identifier(s): 13484494
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 27588, 27596
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 6608, 6609
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100034556, 100047470, 100247447, 100264180, 100293252, 100293648, 100323869, 100332259, 100363490, 100396006, 100421247, 100423677, 100425311, 100465827
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W63887001, W63887002, W63888001, W63888002, W63888003, W63888004
Country: SG	Health Sciences Authority	Identifier(s): 06931P, 09111P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699546010387, 8699546750399
Country: ZA	Health Products Regulatory Authority	Identifier(s): T/7.1/229, T/7.1/230